Atara Biotherapeutics Share Price Today
(NASDAQ: ATRA)

Name: Atara Biotherapeutics Share Price Today (NASDAQ: ATRA) - Atara Biotherapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Atara Biotherapeutics share price is $7.56 & ₹639.77 as on 2 May 2025, 2.30 'hrs' IST

$7.56

▲

-0.43

(-5.38%)

Market is closed - opens 7 PM, 02 May 2025

View live Atara Biotherapeutics share price in Dollar and Rupees. Guide to invest in Atara Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Atara Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Atara Biotherapeutics share price movements

Today's Low: $7.55
Today's High: $8.03
$7.56
0.13%
Downside
Day's Volatility :5.98%
Upside
5.85%
52 Weeks Low: $5.01
52 Weeks High: $19.00
$7.56
33.8%
Downside
52 Weeks Volatility :73.66%
Upside
60.21%

Atara Biotherapeutics (ATRA) Returns

Period	Atara Biotherapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-10.47%	-4.4%	0.0%
6 Months	-18.13%	-5.0%	0.0%
1 Year	-51.1%	-0.1%	0.0%
3 Years	-95.48%	8.4%	-6.1%

Atara Biotherapeutics (ATRA) Key Statistics

in dollars & INR

Previous Close	$7.99
Open	$8.01
Today's High	$8.0299
Today's Low	$7.55
Market Capitalization	$43.5M
Today's Volume	$40.7K
52 Week High	$19.0
52 Week Low	$5.005
Revenue TTM	$128.9M
EBITDA	$-73.3M
Earnings Per Share (EPS)	$-11.41
Profit Margin	-66.24%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-2014.86%

How to invest in Atara Biotherapeutics Stock (ATRA) from India?

It is very easy for Indian residents to invest directly in Atara Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atara Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atara Biotherapeutics or ATRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atara Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atara Biotherapeutics shares which would translate to 0.112 fractional shares of Atara Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atara Biotherapeutics, in just a few clicks!

Returns in Atara Biotherapeutics (ATRA) for Indian investors in Rupees

The Atara Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Atara Biotherapeutics investment value today

Current value as on today

₹47,911

Returns

₹52,089

(-52.09%)

Returns from Atara Biotherapeutics Stock

₹53,506 (-53.51%)

Dollar Returns

₹1,417 (+1.42%)

Indian investors sentiment towards Atara Biotherapeutics (ATRA)

-32%

Period: Apr 1, 2025 to May 1, 2025. Change in 30 Days versus previous period

Search interest for Atara Biotherapeutics Stock from India on INDmoney has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Atara Biotherapeutics

EcoR1 Capital, LLC
9.08%
Redmile Group, LLC
7.54%
Citadel Advisors Llc
4.56%
Bank of America Corp
3.50%
Vanguard Group Inc
3.05%
Vestal Point Capital LP
2.13%

Analyst Recommendation on Atara Biotherapeutics

Rating

Trend

Buy

61%Buy

30%Hold

7%Sell

Based on 13 Wall street analysts offering stock ratings for Atara Biotherapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Atara Biotherapeutics Stock (ATRA)

What analysts predicted

Upside of 85.19%

Target:

$14.00

Current:

$7.56

Insights on Atara Biotherapeutics Stock (Ticker Symbol: ATRA)

Price Movement
In the last 7 days, ATRA stock has moved up by 8.6%
Decreasing Revenue
Revenue is down for the last 2 quarters, 40.19M → 32.75M (in $), with an average decrease of 18.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -21.90M → -12.69M (in $), with an average increase of 72.6% per quarter
ATRA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.1% return, outperforming this stock by 126.2%
ATRA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 89.3% return, outperforming this stock by 184.7%
Price to Sales
ForATRA every $1 of sales, investors are willing to pay $0.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Atara Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Atara Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Atara Biotherapeutics (ATRA) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Atara Biotherapeutics Inc	29.69%	-18.13%	-51.1%	-95.48%	-96.39%
Biontech Se	9.85%	-8.05%	11.13%	-31.31%	123.92%
Regeneron Pharmaceuticals, Inc.	-4.3%	-29.03%	-36.14%	-9.35%	10.5%
Vertex Pharmaceuticals Incorporated	5.32%	8.08%	27.25%	89.22%	92.38%
Alnylam Pharmaceuticals, Inc.	-1.34%	-3.89%	75.14%	84.24%	92.68%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Atara Biotherapeutics Inc	NA	NA	0.0	-5.8	-20.15	-0.36	NA	-16.6
Biontech Se	160.8	NA	0.04	-5.11	-0.03	-0.04	NA	80.89
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.96	39.38	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.38	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Atara Biotherapeutics Inc	Buy	$43.5M	-96.39%	NA	-66.24%
Biontech Se	Buy	$29.5B	123.92%	160.8	-24.18%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	10.5%	15.94	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$129.4B	92.38%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.3B	92.68%	NA	-12.37%

About Atara Biotherapeutics

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Organization	Atara Biotherapeutics
Employees	153
CEO	Dr. Anhco Nguyen Ph.D.
Industry	Health Technology

Management People of Atara Biotherapeutics

Name	Title
Dr. Anhco Nguyen Ph.D.	President, CEO & Director
Ms. Yanina Grant-Huerta	Chief Accounting Officer & Principal Accounting Officer
Alex Chapman	Vice President of Corporate Communications & Investor Relations

Important FAQs about investing in ATRA Stock from India :

What is Atara Biotherapeutics share price today?

Atara Biotherapeutics share price today stands at $7.56, Open: $8.01 ; Previous Close: $7.99 ; High: $8.03 ; Low: $7.55 ; 52 Week High: $19.00 ; 52 Week Low: $5.01.

The stock opens at $8.01, after a previous close of $7.99. The stock reached a daily high of $8.03 and a low of $7.55, with a 52-week high of $19.00 and a 52-week low of $5.01.

Can Indians buy Atara Biotherapeutics shares?

Yes, Indians can invest in the Atara Biotherapeutics (ATRA) from India.

With INDmoney, you can buy Atara Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Atara Biotherapeutics at zero transaction cost.

How can I buy Atara Biotherapeutics shares from India?

It is very easy to buy Atara Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atara Biotherapeutics (ATRA) be purchased?

Yes, you can buy fractional shares of Atara Biotherapeutics with INDmoney app.

What are the documents required to start investing in Atara Biotherapeutics stocks?

To start investing in Atara Biotherapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.